You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0614 Role of wnt antagonists (sclerostin and dkk-1) on bone turnover markers and bone mass, in patients with complete spinal cord injury. preliminary results

Citation Tools

Article menu
Download PDFPDF
Abstracts accepted for publication
Osteoporosis
AB0614 Role of wnt antagonists (sclerostin and dkk-1) on bone turnover markers and bone mass, in patients with complete spinal cord injury. preliminary results

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gifre L, Vidal J, Ruiz-Gaspà S, et al
AB0614 Role of wnt antagonists (sclerostin and dkk-1) on bone turnover markers and bone mass, in patients with complete spinal cord injury. preliminary results
Annals of the Rheumatic Diseases 2013;72:A977.